Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $149.33 USD
Change Today -0.29 / -0.19%
Volume 85.4K
HSIC On Other Exchanges
Symbol
Exchange
Munich
As of 10:17 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

henry schein inc (HSIC) Snapshot

Open
$149.95
Previous Close
$146.65
Day High
$149.95
Day Low
$146.64
52 Week High
07/29/15 - $149.95
52 Week Low
10/16/14 - $109.34
Market Cap
12.5B
Average Volume 10 Days
331.4K
EPS TTM
$5.64
Shares Outstanding
83.6M
EX-Date
--
P/E TM
26.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for HENRY SCHEIN INC (HSIC)

Related News

No related news articles were found.

henry schein inc (HSIC) Related Businessweek News

View More BusinessWeek News

henry schein inc (HSIC) Details

Henry Schein, Inc. provides health care products and services worldwide. It operates in two segments, Health Care Distribution; and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, such as infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, equipment repair, and high-tech and digital restoration equipment. This segment also provides animal health products consisting of branded and generic pharmaceuticals, surgical and consumable products and services, and equipment; and medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services and products, including practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions comprising financial services on a non-recourse basis, e-services, practice technology, network and hardware services, and continuing education services for practitioners. The company primarily serves dental practitioners and laboratories, physician practices, and animal health clinics, as well as government, institutional health care clinics, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

18,000 Employees
Last Reported Date: 05/4/15
Founded in 1932

henry schein inc (HSIC) Top Compensated Officers

Executive Chairman and Chief Executive Office...
Total Annual Compensation: $1.3M
President, Chief Operating Officer, Executive...
Total Annual Compensation: $761.4K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $581.2K
Chief Administrative Officer, Executive Vice ...
Total Annual Compensation: $596.2K
Chief Strategic Officer, Executive Vice Presi...
Total Annual Compensation: $571.2K
Compensation as of Fiscal Year 2014.

henry schein inc (HSIC) Key Developments

Henry Schein, Inc. Promotes Peter McCarthy to President, Henry Schein Global Animal Health Group

Henry Schein, Inc. announced that it has promoted Peter McCarthy to the position of president, Henry Schein Global Animal Health Group. Mr. McCarthy also joins the company's executive management committee. In his new position, Mr. McCarthy will oversee the company's global animal health business, which spans 19 countries, including the United States, Australia, New Zealand, Canada, Malaysia and 14 countries in Europe. Prior to assuming his new position, Mr. McCarthy was President, Henry Schein International, with responsibility for Henry Schein's animal health businesses outside of the United States and Canada. Mr. McCarthy began his career at Henry Schein in 2010 with responsibility for the Company's animal health business in Europe. Before joining Henry Schein, Mr. McCarthy held a variety of positions of increasing responsibility at Schering-Plough Animal Health (now Merck Animal Health) in both the United Kingdom and the United States, before serving as the company's Senior Director, Global Operations and General Manager, China. In these roles, Mr. McCarthy led global business development, as well as strategic planning. Prior to Schering-Plough Animal Health, Mr. McCarthy spent 14 years at Wyeth/American Cyanamid helping to grow its pharmaceutical business. Mr.

Henry Schein, Inc. to Report Q2, 2015 Results on Jul 29, 2015

Henry Schein, Inc. announced that they will report Q2, 2015 results at 9:00 AM, Eastern Standard Time on Jul 29, 2015

Henry Schein, Inc., Q2 2015 Earnings Call, Jul 29, 2015

Henry Schein, Inc., Q2 2015 Earnings Call, Jul 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSIC:US $149.33 USD -0.29

HSIC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cintas Corp $84.47 USD -0.35
Hologic Inc $37.82 USD +0.275
Omnicare Inc $95.75 USD +0.05
Tractor Supply Co $92.22 USD +0.50
Waters Corp $133.49 USD +2.91
View Industry Companies
 

Industry Analysis

HSIC

Industry Average

Valuation HSIC Industry Range
Price/Earnings 26.8x
Price/Sales 1.2x
Price/Book 4.5x
Price/Cash Flow 26.2x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HENRY SCHEIN INC, please visit www.henryschein.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.